Cancer patients and survivors are more likely to report housing and utility insecurity than those who do not have a history of cancer.

In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.

Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...

In this analysis of colorectal cancer patients from 2 clinical trials, researchers aimed to assess the effect of physical activity on overall survival.

Participants in intervention group reported lower rates of moderate-to-very severe symptoms, including anxiety, depression, pain, fatigue, constipation.